Phase I Trial of Endocavitary Injection of Bone Marrow Derived CD133+ Cells in Ischemic Refractory Cardiomyopathy (RECARDIO Trial)

计划入组 12 人 · 首次发布于 2014 年 2 月 11 日

Use of Beta-blockers and Risk of New Onset Diabetes

计划入组 12,336 人 · 首次发布于 2012 年 4 月 30 日

EXERT-BC Cardio: Cardio or Conditioning Training With Breast Cancer

计划入组 40 人 · 首次发布于 2026 年 7 月 31 日

Cardio-spect(Cardiolite)

C₂₄H₄₄BCuF₄N₄O₄

CellBead Cardio (CellMed)

CellBead Cardio(BTG Ltd.)

Recardio, Inc.

United States

Swiss Cardio Technologies AG

Switzerland

Hospital de Niños Dr. Ricardo Gutierrez

Argentina

Kancera Advances Cardiovascular Drug Pipeline with Recardio Partnership and FDA Engagement

Kancera Receives FDA Fast Track Eligibility for KAND567 in Heart Attack Treatment

FDA Approves Merck's Recarbrio for Complex Infections with Antimicrobial Stewardship Focus